Filana Therapeutics (FLNA) Asset Utilization Ratio (2011 - 2013)

Filana Therapeutics (FLNA) posted quarterly Asset Utilization Ratio of 0.81 for Q4 2013, up 407.84% quarter-over-quarter from 0.16 in Q3 2013.

Filana Therapeutics (FLNA) Asset Utilization Ratio (2011 - 2013) Analysis & Trends

Filana Therapeutics' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.81 for Q4 2013.

In Q4 2013, Asset Utilization Ratio changed N/A year-over-year to 0.81; the TTM figure through Dec 2013 stood at 0.81 (changed N/A YoY), while the FY2013 annual figure was 0.77, up 450.06% from the prior year.
Asset Utilization Ratio for Q4 2013 stood at 0.81, up from 0.16 in the prior quarter.
The five-year high for Asset Utilization Ratio was 0.81 in Q4 2013, with the low at 0.11 in Q1 2012.
The 3-year median for Asset Utilization Ratio is 0.16 (2011), against an average of 0.24.
Peak annual rise in Asset Utilization Ratio reached 54.2% in 2013, while the deepest fall reached 54.2% in 2013.
Filana Therapeutics' Asset Utilization Ratio stood at 0.12 in 2011, then dropped by 0.4% to 0.11 in 2012, then jumped by 604.31% to 0.81 in 2013.
Business Quant data shows FLNA's Asset Utilization Ratio at 0.81 in Q4 2013, 0.16 in Q3 2013, and 0.17 in Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	139.41 Bn	131.56 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	86.14 Bn	78.15 Bn	3.93 Bn	0.38
3	Argenx Se	65.52 Bn	60.34 Bn	1.37 Bn	-
4	Moderna	58.21 Bn	53.07 Bn	52.00 Mn	0.20
5	BeOne Medicines	42.15 Bn	37.05 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.62 Bn	28.31 Bn	992.69 Mn	0.90
7	BioNTech SE	27.95 Bn	9.56 Bn	668.28 Mn	0.13
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.30 Bn	26.46 Bn	-	0.13
10	Filana Therapeutics	46.14 Mn	46.14 Mn	-	-

Download Data